Skip to main content
Fig. 1 | Experimental Hematology & Oncology

Fig. 1

From: New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies

Fig. 1

Western blot of CD20 expression. Western blotting of different samples collected from patients carrying B malignancies. CLL chronic lymphoid leukemia, NHL non-Hodgkin lymphoma, CBL cutaneous b lymphoma. Three B cell lines were included as well as samples from healthy donors as controls. β-actin was used as a protein-loading control. CD20 expression detection was performed using a C-terminal polyclonal CD20 antibody. (*) showed additional bands excluding wt- and D393-CD20 protein signals. Chemiluminescence time exposure was 5 min

Back to article page